Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types

Published on Dec 1, 2019in BMC Medical Genomics2.57
· DOI :10.1186/s12920-019-0579-3
Zhishan Chen (VUMC: Vanderbilt University Medical Center), Wanqing Wen51
Estimated H-index: 51
(VUMC: Vanderbilt University Medical Center)
+ 6 AuthorsXingyi Guo23
Estimated H-index: 23
(VUMC: Vanderbilt University Medical Center)
Although APOBEC-mutational signature is found in tumor tissues of multiple cancers, how a common germline APOBEC3A/B deletion affects the mutational signature remains unclear. Using data from 10 cancer types generated as part of TCGA, we performed integrative genomic and association analyses to assess inter-relationship of expressions for isoforms APOBEC3A and APOBEC3B, APOBEC-mutational signature, germline APOBEC3A/B deletions, neoantigen loads, and tumor infiltration lymphocytes (TILs). We found that expression level of the isoform uc011aoc transcribed from the APOBEC3A/B chimera was associated with a greater burden of APOBEC-mutational signature only in breast cancer, while germline APOBEC3A/B deletion led to an increased expression level of uc011aoc in multiple cancer types. Furthermore, we found that the deletion was associated with elevated APOBEC-mutational signature, neoantigen loads and relative composition of T cells (CD8+) in TILs only in breast cancer. Additionally, we also found that APOBEC-mutational signature significantly contributed to neoantigen loads and certain immune cell abundances in TILs across cancer types. These findings reveal new insights into understanding the genetic, biological and immunological mechanisms through which APOBEC genes may be involved in carcinogenesis, and provide potential genetic biomarker for the development of disease prevention and cancer immunotherapy.
  • References (48)
  • Citations (0)
#1Amélie Boichard (University of California, Berkeley)H-Index: 4
Last.Razelle Kurzrock (University of California, Berkeley)H-Index: 95
view all 9 authors...
#1Shixiang Wang (CAS: Chinese Academy of Sciences)H-Index: 1
#2Mingming Jia (CAS: Chinese Academy of Sciences)H-Index: 1
Last.Xue-Song Liu (ShanghaiTech University)H-Index: 13
view all 4 authors...
#1Xingyi Guo (VUMC: Vanderbilt University Medical Center)H-Index: 23
#2Jiajun Shi (VUMC: Vanderbilt University Medical Center)H-Index: 2
Last.David H. Hunter (Harvard University)H-Index: 178
view all 14 authors...
#1Liv Beathe GansmoH-Index: 6
#2Paal Romundstad (NTNU: Norwegian University of Science and Technology)H-Index: 6
Last.Stian Knappskog (University of Bergen)H-Index: 26
view all 7 authors...
#1Sathana Dushyanthen (Peter MacCallum Cancer Centre)H-Index: 7
#2Zhi Ling Teo (University of Melbourne)H-Index: 11
Last.Michael H. Kershaw (University of Melbourne)H-Index: 38
view all 18 authors...
#1Nicolas Jacquelot (French Institute of Health and Medical Research)H-Index: 11
#2María Paula Roberti (French Institute of Health and Medical Research)H-Index: 9
Last.Yaron Meirow (HUJI: Hebrew University of Jerusalem)H-Index: 4
view all 50 authors...
#1Abctb Investigators (University of Melbourne)H-Index: 1
#2kConFab (Peter MacCallum Cancer Centre)H-Index: 2
Last.Aocs Investigators (University of Melbourne)H-Index: 1
view all 3 authors...
#1Dung T. Le (Johns Hopkins University)H-Index: 30
#2Jennifer N. Durham (Johns Hopkins University)H-Index: 3
Last.Brandon Luber (Johns Hopkins University)H-Index: 18
view all 46 authors...
Cited By0